Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

      Share Article
      share to

      New Brunswick, NJ (June 17, 2014) - Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 15th, to review second-quarter results. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Dominic Caruso, Vice President, Finance and Chief Financial Officer; Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson and Worldwide Chairman, Pharmaceuticals; Joaquin Duato, Worldwide Chairman, Pharmaceuticals; and Louise Mehrotra, Vice President, Investor Relations, will host the call.

      Investors and other interested parties may access the conference call in the following ways:

      • At Johnson & Johnson’s website: www.investor.jnj.com. This earnings webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads. A webcast and podcast replay will be available approximately two hours after the conference call concludes.
      • By telephone: For both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 855-269-0554. For participants outside the U.S., the dial-in number is 424-276-6827. The conference ID number for all callers is 59095750. A replay of the conference call will be available beginning at approximately 12:00 p.m. on

      July 15, 2014, and ending at approximately 12:00 a.m. on July 22, 2014. The replay dial-in number for U.S. participants is 855-859-2056. For participants outside the U.S., the replay dial-in number is 404-537-3406. The replay conference ID number for all callers is 59095750.

      About Johnson & Johnson
      Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,300 employees at more than 275 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

      ###

      Press Contacts:
      Ernie Knewitz
      (732) 524-6623
      (917) 697-2318 (M)

      Amy Jo Meyer
      (732) 524-6678
      (908) 616-6250 (M)

      Investor Contacts:
      Louise Mehrotra
      (732) 524-6491

      Lisa Romanko
      (732) 524-2524

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.